ALPHANOW
LIVE

Serial Number

98013089

Owner

ARTBIO, Inc.

Attorney

Christina M. Licursi

Filing Date

May 25, 2023

Add to watchlist:

No watchlists yet
View on USPTO

ALPHANOW Trademark

Serial Number: 98013089

ALPHANOW is a trademark filed by ARTBIO, Inc. on May 25, 2023. The trademark is classified under Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

ARTBIO, Inc. (5 trademarks)

c/o F-Prime Capital
Cambridge, MA 02142

Entity Type: 03

Trademark Details

Filing Date

May 25, 2023

Registration Date

Not Registered

Goods & Services

Radiation therapy devices; implantable drug delivery devices, namely a radionuclide generator for targeted radiopharmaceutical therapy

Drug delivery agents consisting of compounds that facilitate delivery of targeted radiation therapy; pharmaceutical preparations for use in targeted radiation therapy; pharmaceutical preparations for the treatment of cancer

Pharmaceutical and biotechnological research in the areas of pharmaceutical products and radiation therapy for the prevention and treatment of medical conditions; pharmaceutical and biotechnological research and development in the fields of targeted radiation therapy, immune modulation, infection, injury, inflammation, oncology/cancer, radiology, infectious, genetic, and autoimmune diseases, and radiation therapies; none of the foregoing for or related to expert network services and expert network research services, including, without limitation, for the purpose of capturing, profiling and extracting details of professionals and their specialist business and industrial expertise and talent, or software engineering services, namely, relating to the provision of learning and networking opportunities, lead generation and sale facilitation for owners of specialist technical, engineering, and industrial subject matter expertise in the form of telephone and in-person consultations, polls, surveys, valuations, assessments, consulting projects, recruitment, search, interim management and placement assignments, or providing information, consultancy and advisory services in respect of the aforesaid

Filing History

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 22, 2026 GNS3
LETTER OF SUSPENSION E-MAILED
May 22, 2026 GNSL
SUSPENSION LETTER WRITTEN
May 22, 2026 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
May 15, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 14, 2026 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
May 14, 2026 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 8, 2026 GNS3
LETTER OF SUSPENSION E-MAILED
May 8, 2026 GNSL
SUSPENSION LETTER WRITTEN
May 8, 2026 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 29, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 29, 2026 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Apr 29, 2026 ERSI
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 6, 2026 RCSC
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jan 5, 2026 RCCK
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jul 2, 2025 RCSC
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 4, 2025 TCCA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 4, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 4, 2025 COAR
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 3, 2025 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Mar 2, 2024 GNS3
LETTER OF SUSPENSION E-MAILED
Mar 2, 2024 GNSL
SUSPENSION LETTER WRITTEN
Mar 2, 2024 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 22, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 22, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 22, 2024 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 19, 2024 GNRN
NON-FINAL ACTION E-MAILED
Feb 19, 2024 GNRT
NON-FINAL ACTION WRITTEN
Feb 19, 2024 CNRT
ASSIGNED TO EXAMINER
Feb 19, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 26, 2023 NWOS